|
|
|
||||||||
 |
||||||||
| Publications |
| Immunosuppression/Immunodeficiency and Cancer |
| Links for the following articles have been provided for you as available. They will take you to the PubMed search page at the National Center for Biotechnology Information to view IPITTR publications. When you are finished with the PubMed site simply close the browser window to return to IPITTR. |
|
Harris JP, Penn I: Immunosuppression and development of malignancies of the upper airway. Laryngoscope 91:520-528, 1981.
Immunosuppression and Merkel cell cancer. Translant Proc 2002 Aug;34(5):1780-1 Penn I, Brunson ME: Cancers following cyclosporine therapy. Transplant Proc 20 (Suppl 3):885-892, 1988. Penn I, First MR: Development and incidence of cancer following cyclosporine therapy. Transplant Proc 18:210-213, 1986. Penn I, Starzl TE: Immunosuppression and cancer. Transplant Proc 5:943-947, 1973. Penn I, Starzl TE: Immunosuppression and neoplasia. ALG Therapy and Standardization Workshop. Behring Institute Research Communications No. 51, Behring-Werke, Marburg, West Germany. (ed Seiler FR and Schwick HG) pp. 204-208, 1972. Penn I, Starzl TE: The effect of immunosuppression on cancer. In Seventh National Cancer Conference Proceedings. Philadelphia, J.B. Lippincott Co., pp. 425-436, 1973. Penn I: Cancer associated with immunosuppression. Chapter in CRC Handbook Series in Clinical Laboratory Science. Section F: Immunology Vol. 1, Part 2 (eds Baumgarten A and Richards FF) Cleveland, Ohio CRC Press Inc., pp. 365-375, 1979. Penn I: Cancer following cyclosporine therapy. Transplant Proc 19:2211-2213, 1987. Penn I: Cancer in immunosuppressed patients. In Symposia Medica Hoechst 21 The Nature, Cellular and Biochemical Basis and Management of Immunodeficiencies. (eds Good RA and Lindenlaub E). F.K. Shattauer Verlag, Stuttgart, pp. 271-288, 1987. Penn I: Cancer in immunosuppressed patients. Transplant Proc 16:492-494, 1984. Penn I: Cancer in immunosuppressed patients. Transplant Proc 7 (Suppl. 1) 553-555, 1975. Penn I: Cancer in the immunosuppressed organ recipient. Transplant Proc 23:1771-1772, 1991. Penn I: Cancer is a long-term hazard of immunosuppressive therapy. In Immunointervention in Autoimmune Diseases (ed Bach JF). London Academic Press, pp. 49-62, 1989. Penn I: Cancer is a long-term hazard of immunosuppressive therapy. J Autoimmunity 1:545-558, 1988. Penn I: Cancers after cyclosporine therapy. Transplant Proc 20(Suppl):276-279, 1988. Penn I: Cancers following cyclosporine therapy. Transplantation 43:32-34, 1987. Penn I: Chemical immunosuppression and human cancer. Cancer 34:1474-1480, 1974. Penn I: Cyclosporine and oncogenesis. Mount Sinai J Med 54:460-464, 1987. Penn I: Depressed immunity and the development of cancer: A review. Clin Exp Immunol 46:459-474, 1981. Penn I: Immunosuppression and cancer: Importance in head and neck surgery. Arch Otolaryngol 101:667-670, 1975. Penn I: Immunosuppression and malignant disease. Chapter in Comprehensive Immunology – 4 – The Immunopathology of Lymphoreticular Neoplasms (eds Twomey JJ and Good RA) Plenum Medical Book Company, New York, pp. 223-237, 1978. Penn I: Immunosuppression and opportunistic tumors: Do viruses play a role? In Advances in tumor immunology and allergic disorders, Immuno Incontri (ed F. Dammacco). Milan, Edi. Ermes, pp. 139-162, 1992 Penn I: Immunosuppressive agents, immunodeficiency states and malignancy. In Lieberman R and Mukherjee A (Eds), Principles of Drug Development in Transplantation and Autoimmunity, Austin, Texas, RG Landes, New York, Chapman and Hall, pp. 93-102, 1996. Penn I: Malignancies associated with immune deficiencies. In Comprehensive Textbook of Oncology, (eds Moossa AR, Schimpf SC and Robson MC), Second Edition Baltimore, Williams and Wilkins Co., pp. 115-119, 1991. Penn I: Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83:492-502, 1978. Penn I: Malignancies following the use of Cyclosporin A in man. Cancer Surveys 1(4):621-624, 1983. Penn I: Malignant disease in immunodeficient states in man. In Recent Results in Cancer Research (eds Grundmann E and Gross R) Vol. 52:96-106, 1975. Penn I: Malignant neoplasia in the immunocompromised patient. In The Transplantation and Replacement of Thoracic Organs. The present status of biological and mechanical replacement of the heart and lungs. (eds Cooper DKC and Novitzky D) Dordrecht Kluwer Academic Publishers, pp. 183-190, 1990. Penn I: Mechanisms of therapy induced malignancies – editorial review. Cancer Surveys 1(4):763-782, 1983. Penn I: Neoplastic consequences of immunosuppression. In Immunotoxicology and Immunopharmacology. (eds Dean JH, Luster MI, Munson AE, Amos H) New York, Raven Press, pp. 79-89, 1985. Penn I: Occurrence of cancers in immunosuppressed organ transplant recipients. In Clinical Transplants 1994, Terasaki PI and Cecka JM (Eds). UCLA Tissue Typing Laboratory, pp. 99-109, 1995. Penn I: Occurrence of malignancies in immunosuppressed organ transplant recipients. In Organ Transplantation 1990 (eds Abouna GM, Kumar MSA, White AG). Dordrecht, Kluwer Academic Publishers, pp. 475-483, 1991. Penn I: Second malignant neoplasms associated with immunosuppressive medications. Cancer 37:1024-1032, 1976. Penn I: The neoplastic consequences of immunodepression. In Immunotoxicology. (eds Berlin A, Deal J, Draper MH, Smith EMB, Spreafico F). Dordrecht, Martinus Nijhoff Publishers, pp. 69-82, 1987. Penn I: The occurrence of cancer in immune deficiencies. Current Problems in Cancer 6(10) 1-64, April 1982. Penn I: The occurrence of malignant tumors in immunosuppressed states. In Acquired Immunodeficiency Syndrome (ed Klein E) Basel, Karger. (Progress in Allergy Series) Vol. 37, pp. 259-300, 1986.` Penn I: Why do immunosuppressed patients develop cancer? In CRC Critical Reviews in Oncogenesis (ed Pimentel E). Boca Raton, Florida CRC Press Inc., Vol. 1, pp. 27-52, 1989. Porreco R, Penn I, Droegemueller W, Greer B, Makowski E: Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynec 45:359-364, 1975. Schwartz RS, Penn I: Immunosuppression and neoplasia. Transplant Proc 7 (Suppl. 1) 899-900, 1975. Starzl TE, Penn I, Halgrimson CG: Immunosuppression and malignant neoplasms. (letter to the editor) New Eng J Med 283:934, 1970. The role of immunosuppression in lymphomas. Recent Results Cancer Res 2002;159:55-66. Review. |
| Return to publication categories. |
| Searches and abstracts provided by the United States National Library of Medicine (NLM) and PubMed. The National Center for Biotechnology Information's disclaimer and copyright notice applies to these linked resources. The NLM does not hold the copyright on the abstracts found in PubMed; the journal publishers do. NLM provides no legal advice concerning distribution of copyrighted materials. This advice should be sought from your legal counsel. |
|
|
|
Copyright © 2007. University of Cincinnati. All Rights Reserved. |
|